loadpatents
name:-0.012560129165649
name:-0.0086891651153564
name:-0.00048184394836426
Geroni; Maria Cristina Patent Filings

Geroni; Maria Cristina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Geroni; Maria Cristina.The latest application filed is for "pharmaceutical composition of an anthracycline".

Company Profile
0.7.11
  • Geroni; Maria Cristina - Milan IT
  • Geroni; Maria Cristina - Milano IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical composition of an anthracycline
Grant 8,940,334 - Geroni , et al. January 27, 2
2015-01-27
Pharmaceutical Composition Of An Anthracycline
App 20120121716 - Geroni; Maria Cristina ;   et al.
2012-05-17
Antitumor Combination Comprising A Morpholinyl Anthracycline Derivative And Demethylating Agents
App 20110021517 - Geroni; Maria Cristina ;   et al.
2011-01-27
Morpholinyl Anthracycline Derivative Combined With Protein Kinase Inhibitors
App 20100190736 - Geroni; Maria Cristina ;   et al.
2010-07-29
Antitumor Combination Comprising A Morpholinyl Anthracycline And An Antibody
App 20100104566 - Geroni; Maria Cristina
2010-04-29
Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their Receptors
App 20090074757 - Pesenti; Enrico ;   et al.
2009-03-19
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
App 20070249651 - Geroni; Maria Cristina ;   et al.
2007-10-25
Method for optimizing therapeutic efficacy of nemorubicin
App 20060183168 - Geroni; Maria Cristina ;   et al.
2006-08-17
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
App 20060084612 - Geroni; Maria Cristina ;   et al.
2006-04-20
Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
Grant 7,030,089 - Geroni , et al. April 18, 2
2006-04-18
Glutathiaone conjugates with distamycin derivatives having antitumoral activity
Grant 6,838,547 - Beria , et al. January 4, 2
2005-01-04
Glutathiaone conjugates with distamycin derivatives having antitumoral activity
App 20040038905 - Beria, Italo ;   et al.
2004-02-26
Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
App 20030207794 - Geroni, Maria Cristina ;   et al.
2003-11-06
Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase I and II inhibitors
App 20030162722 - Geroni, Maria Cristina ;   et al.
2003-08-28
Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents
Grant 6,596,845 - Cozzi , et al. July 22, 2
2003-07-22
Combined preparations comprising morpholine anthracyclines and anticancer agent
Grant 6,586,428 - Geroni , et al. July 1, 2
2003-07-01
Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
Grant 6,165,980 - Cozzi , et al. December 26, 2
2000-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed